GlassScriptPhysician profile
Gary D Milius
NPI 1740393610
$2,962.03
in general payments reported to CMS, 2019-2025
33 companies · $613 in 2025
The $613 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2020: $171 · 2021: $196 · 2022: $493 · 2023: $652 · 2024: $560 · 2025: $613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,824.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $561.60 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $458.41 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $215.31 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $174.63 | 2022-2025 | |
| Biogen, INC. | $162.15 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $130.48 | 2021-2025 | Slynd |
| Organon LLC | $127.93 | 2022-2025 | Nexplanon |
| Intuitive Surgical, INC. | $112.88 | 2023 | Da Vinci Surgical System |
| Coopersurgical, INC. | $103.07 | 2020-2023 | Paragard T 380a |
| Daiichi Sankyo INC. | $97.46 | 2022-2024 | Injectafer |
| Pfizer INC. | $96.35 | 2021-2025 | |
| Myovant Sciences INC. | $89.58 | 2022 | |
| Merck Sharp & Dohme LLC | $66.99 | 2019-2024 | Gardasil 9, Gardasil, Capvaxive |
| Therapeuticsmd, INC. | $66.73 | 2020-2022 | |
| Octapharma USA, INC. | $62.37 | 2025 | Fibryga |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $52.14 | 2023-2024 | Myfembree |
| Becton, Dickinson and Company | $50.09 | 2023 | Bd Onclarity, Bd Max System, Bd Max Instrument |
| Allergan, INC. | $36.21 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $31.60 | 2019-2020 | |
| Teleflex LLC | $28.94 | 2023 | Quikclot |
| Covidien LP | $28.02 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $26.60 | 2022 | |
| Smith+Nephew, INC. | $25.73 | 2022-2025 | Pico |
| Convatec INC. | $18.39 | 2025 | |
| Baxter Healthcare | $17.51 | 2022 | |
| Hologic Sales and Service, LLC | $17.02 | 2024 | Coolseal Generator, Acessa Provu System |
| Pacira Pharmaceuticals Incorporated | $16.65 | 2025 | Exparel |
| Meditrina | $15.97 | 2021 | |
| Medtronic, INC. | $15.54 | 2022 | |
| Lilly USA, LLC | $15.43 | 2025 | Zepbound |
| Amgen INC. | $14.54 | 2019 | |
| Pharmacosmos Therapeutics INC. | $12.90 | 2023 | Monoferric |
| Boston Scientific Corporation | $12.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Milius listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.